Heterogeneous Type 4 Enhancement of Hepatocellular Carcinoma on Dynamic CT Is Associated With Tumor Recurrence After Radiofrequency Ablation

被引:53
|
作者
Kawamura, Yusuke [1 ]
Ikeda, Kenji [1 ]
Seko, Yuya [1 ]
Hosaka, Tetsuya [1 ]
Kobayashi, Masahiro [1 ]
Saitoh, Satoshi [1 ]
Kumada, Hiromitsu [1 ]
机构
[1] Toranomon Gen Hosp, Dept Hepatol, Minato Ku, Tokyo 1058470, Japan
关键词
dynamic CT; hepatocellular carcinoma; radiofrequency ablation; recurrence; surgical resection; PROGNOSTIC-FACTORS; RISK-FACTORS; HEPATECTOMY; UNIVARIATE; RESECTION;
D O I
10.2214/AJR.11.6843
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OBJECTIVE. The aim of this study was to predict recurrence of hepatocellular carcinoma (HCC) from baseline dynamic CT images. MATERIALS AND METHODS. This retrospective study included 191 consecutive patients who underwent surgical resection or radiofrequency ablation (RFA) between January 2005 and September 2009 for the treatment of HCC. Enhancement on pretreatment arterial and portal phase dynamic CT images was classified into one of the four following enhancement patterns: Types 1 and 2 are homogeneous enhancement patterns without or with increased arterial blood flow, respectively; type 3 is a heterogeneous enhancement pattern with septations; and type 4 is an irregularly shaped ring structure enhancement pattern. Predictive factors for tumor recurrence including dynamic CT enhancement pattern were also evaluated. Moreover, risk factors including recurrence type (i.e., tumor number >= 10, portal vein invasion, or both) were evaluated in RFA-treated cases. RESULTS. Among 60 patients who underwent surgical resection, no statistical association was observed between dynamic CT enhancement patterns and recurrence rate. In contrast, in the 131 patients who underwent RFA, cumulative recurrence rates for each enhancement pattern were significantly different: Recurrence rates 2 years after RFA for patients with type 1, 2, 3, and 4 were 26.6%, 46.9%, 38.6%, and 77.8%, respectively (p = 0.042). Recurrence, which was defined as the presence of 10 or more nodules, portal vein invasion, or both occurred in nine of 131 patients (6.9%) in the RFA group. A multivariate Cox proportional hazards analysis revealed that the type 4 dynamic CT enhancement pattern is an independent factor for HCC recurrence (hazard ratio, 27.68; 95% CI, 6.82-112.33; p < 0.001). CONCLUSION. The pretreatment type 4 dynamic CT enhancement pattern can potentially be used to predict recurrence of HCC after RFA treatment.
引用
收藏
页码:W665 / W673
页数:9
相关论文
共 50 条
  • [31] Local Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma: Treatment Choice and Outcome
    Xie, Xiaoyan
    Jiang, Chunlin
    Peng, Zhengwei
    Liu, Baoxian
    Hu, Wenjie
    Wang, Ye
    Lin, Manxia
    Lu, Mingde
    Kuang, Ming
    JOURNAL OF GASTROINTESTINAL SURGERY, 2015, 19 (08) : 1466 - 1475
  • [32] Using transient elastography to predict hepatocellular carcinoma recurrence after radiofrequency ablation
    Lee, Yu Rim
    Park, Soo Young
    Kim, Seung Up
    Jang, Se Young
    Tak, Won Young
    Kweon, Young Oh
    Kim, Beom Kyung
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Han, Kwang-Hyub
    Hur, Keun
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 (05) : 1079 - 1086
  • [33] Viable residual tumor tissue after radiofrequency ablation treatment in hepatocellular carcinoma: evaluation with CT perfusion
    Ippolito, Davide
    Bonaffini, Pietro Andrea
    Capraro, Cristina
    Leni, Davide
    Corso, Rocco
    Sironi, Sandro
    ABDOMINAL IMAGING, 2013, 38 (03): : 502 - 510
  • [34] Local recurrence of hepatocellular carcinoma after radiofrequency ablation associates with the safety margin of the complete ablation
    Nakazawa, T
    HEPATOLOGY, 2005, 42 (04) : 383A - 384A
  • [35] Viable residual tumor tissue after radiofrequency ablation treatment in hepatocellular carcinoma: evaluation with CT perfusion
    Davide Ippolito
    Pietro Andrea Bonaffini
    Cristina Capraro
    Davide Leni
    Rocco Corso
    Sandro Sironi
    Abdominal Imaging, 2013, 38 : 502 - 510
  • [36] Local recurrence of hepatocellular carcinoma in the tumor blood drainage area following radiofrequency ablation
    Hirooka, Masashi
    Ochi, Hironori
    Koizumi, Yohei
    Tokumoto, Yoshio
    Hiraoka, Atsushi
    Kumagi, Teru
    Abe, Masanori
    Tanaka, Hiroaki
    Hiasa, Yoichi
    MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (02) : 182 - 186
  • [37] Application of Gemstone CT Spectroscopy in the Evaluation of Abnormal Enhancement of Lesion Margin After Radiofrequency Ablation of Hepatocellular Carcinoma
    Yan, Yuchang
    Jiang, Tao
    Yang, Zhenghan
    Wang, Zhenchang
    Jin, Erhu
    Pan, Zhenyu
    IRANIAN JOURNAL OF RADIOLOGY, 2020, 17 (04) : 1 - 8
  • [38] Enhancement of tumor-associated antigen-specific T cell responses by radiofrequency ablation of hepatocellular carcinoma
    Mizukoshi, Eishiro
    Yamashita, Tatsuya
    Arai, Kuniaki
    Sunagozaka, Hajime
    Ueda, Teruyuki
    Arihara, Fumitaka
    Kagaya, Takashi
    Yamashita, Taro
    Fushimi, Kazumi
    Kaneko, Shuichi
    HEPATOLOGY, 2013, 57 (04) : 1448 - 1457
  • [39] ENHANCEMENT OF TUMOR-ASSOCIATED ANTIGEN-SPECIFIC T CELL RESPONSES BY RADIOFREQUENCY ABLATION OF HEPATOCELLULAR CARCINOMA
    Mizukoshi, Eishiro
    Arihara, Fumitaka
    Yamashita, Tatsuya
    Arai, Kuniaki
    Sunagozaka, Hajime
    Ueda, Teruyuki
    Kagaya, Takashi
    Yamashita, Taro
    Fushimi, Kazumi
    Kaneko, Shuichi
    HEPATOLOGY, 2011, 54 : 1377A - 1377A
  • [40] Hemobilia after radiofrequency ablation of hepatocellular carcinoma
    Rhim, Hyunchul
    Lim, Hyo K.
    Kim, Young-Sun
    Choi, Dongil
    Lee, Kyu Taek
    ABDOMINAL IMAGING, 2007, 32 (06): : 719 - 724